Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma

Tekijä Ogura, Satoshi, Yoshida, Yuichi, Kurahashi, Tomohide, Egawa, Mayumi, Furuta, Kunimaro, Kiso, Shinichi, Kamada, Yoshihiro, Hikita, Hayato, Eguchi, Hidetoshi, Ogita, Hisakazu, Doki, Yuichiro, Mori, Masaki, Tatsumi, Tomohide, Takehara, Tetsuo
Julkaisussa Oncotarget (2018)

Forkhead Box M1 Transcription Factor Drives Liver Inflammation Linking to Hepatocarcinogenesis in Mice

Tekijä Kurahashi, Tomohide, Yoshida, Yuichi, Ogura, Satoshi, Egawa, Mayumi, Furuta, Kunimaro, Hikita, Hayato, Kodama, Takahiro, Sakamori, Ryotaro, Kiso, Shinichi, Kamada, Yoshihiro, Wang, I-Ching, Eguchi, Hidetoshi, Morii, Eiichi, Doki, Yuichiro, Mori, Masaki, Kalinichenko, Vladimir V., Tatsumi, Tomohide, Takehara, Tetsuo
Julkaisussa Cell Mol Gastroenterol Hepatol (2019)